CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BrainCAV focuses on developing a gene therapy using canine adenovirus type 2 vectors to treat neurodegenerative diseases, specifically targeting mucopolysaccharidosis type VII and Parkinson's disease. The project aims to enhance neuron-specific gene delivery while addressing safety and efficacy challenges, moving towar…
Formidable challenges remain to prevent and treat successfully neurodegenerative diseases.
Traditional pharmacological approaches, as well as those using stem cells, have made progress but their impact remain limited.
As suggested by clinical results in Canavan and Parkinson’s disease, gene transfer offers substantial potential.
However, this strategy of therapeutic intervention also brings unique obstacles - in particular the need to address feasibility, efficacy and safety.
BrainCAV's fou…
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
